C9-methylated glucosylceramide is a fungus-specific sphingolipid. This lipid is a major membrane component in the cell and is thought to play important roles in the growth and virulence of several fungal species. To investigate the importance of the methyl branch of the long-chain base in glucosylceramides in pathogenic fungi, we identified and characterized a sphingolipid C9-methyltransferase gene (MTS1, C9-MethylTransferase for Sphingolipid 1) in the pathogenic yeast Candida albicans. The mts1 disruptant lacked (E,E)-9-methylsphinga-4,8-dienine in its glucosylceramides and contained (E)-sphing-4-enine and (E,E)-sphinga-4,8-dienine. Reintroducing the MTS1 gene into the mts1 disruptant restored the synthesis of (E,E)-9-methylsphinga-4,8-dienine in the glucosylceramides. We also created a disruptant of the HSX11 gene, encoding glucosylceramide synthase, which catalyses the final step of glucosylceramide synthesis, in C. albicans and compared this mutant with the mts1 disruptant. The C. albicans mts1 and hsx11 disruptants both had a decreased hyphal growth rate compared to the wild-type strain. The hsx11 disruptant showed increased susceptibility to SDS and fluconazole, similar to a previously reported sld1 disruptant that contained only (E)-sphing-4-enine in its glucosylceramides, suggesting that these strains have defects in their cell membrane structures. In contrast, the mts1 disruptant grew similarly to wild-type in medium containing SDS or fluconazole. These results suggest that the C9-methyl group of a long-chain base in glucosylceramides plays an important role in the hyphal elongation of C. albicans independent of lipid membrane disruption.
INTRODUCTION
Glycosphingolipids, which consist of a ceramide with various sugars, are ubiquitous membrane lipids in eukaryotic organisms. They are classified by their characteristic polar headgroups. One type of glycosphingolipid, glycosylinositolphosphorylceramide (GIPC), is linked with inositol via a phosphodiester bond and is present only in fungi and plants. On the other hand, glycosylceramides (GlyCers), which are directly linked to a glucosyl or galactosyl residue, can form the base for further glycosylations. Glucosylceramides (GluCers), which contain a directly linked glucose residue, are unique glycosphingolipids that are found in animals, plants and fungi, whereas galactosylceramides, which are linked with galactose, are found only in animals and fungi (reviewed by Warnecke & Heinz, 2003) .
In animals, GlyCers are not only essential for growth but are also thought to play a crucial role in cell differentiation and cell-cell interactions (reviewed by Merrill et al., 1997; Ternes et al., 2002) . Plant GlyCers and their components such as ceramide and long-chain bases (LCBs) have been suggested to function in signal transduction and hostpathogen interactions (reviewed by Sperling & Heinz, 2003; Thevissen et al., 2004; Ramamoorthy et al., 2007) . Although two yeast species, Saccharomyces cerevisiae and Schizosaccharomyces pombe, have been used as models to study the metabolism and function of sphingolipids in higher eukaryotic cells, these species are not capable of synthesizing GlyCers. Therefore, our understanding of the molecular mechanisms that contribute to the function of GlyCer in fungi is still limited.
Recently, a number of fungal pathogens have been reported to contain GluCers that play functional roles in growth and differentiation. The addition of antibodies against a purified fungal GluCer inhibited cell budding and growth in Cryptococcus neoformans, and antibodies against a purified Pseudallescheria boydii GluCer inhibited mycelium formation in P. boydii and germ-tube formation in Candida albicans (Rodrigues et al., 2000; Pinto et al., 2002) . Inhibiting glucosylceramide synthase, which catalyses the final step in GluCer synthesis, influences the growth and differentiation of Aspergillus nidulans and Aspergillus fumigatus (Levery et al., 2002) . Moreover, additional evidence has emerged that GluCers play important roles in IP: 54.70.40.11
On: Thu, 03 Jan 2019 20:56:29 fungal pathogenicity. A Dgcs1 strain of Cr. neoformans, which lacks GluCer, is avirulent, and the virulence of a Fusarium graminearum Dgcs1 (DFggcs1) strain in wheat is highly compromised (Ramamoorthy et al., 2007) . However, it is still unknown what part(s) of the GluCer molecular structures cause(s) these biological phenomena in fungi.
GluCer biosynthesis starts with the condensation of palmitoyl-CoA and serine by serine palmitoyltransferase to form 3-ketosphinganine (reviewed by Warnecke & Heinz, 2003) . 3-Ketosphinganine reductase catalyses the conversion of 3-ketosphinganine to sphinganine. Ceramide synthase catalyses the condensation of sphinganine to saturated acyl-CoA for the synthesis of ceramides. Next, sphingolipid D
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-desaturase catalyses the D 4 -desaturation of LCB in ceramides (Ternes et al., 2002) . In many plants and fungi, sphingolipid D 8 -desaturase catalyses the D 8-desaturation of LCB in ceramides, while sphingolipid C9-methyltransferase introduces a methyl group at C9 of LCB in ceramides (Sperling et al., 1998; Takakuwa et al., 2002; Ternes et al., 2006) . The desaturation of fatty acyl groups in ceramides has also been detected in some organisms (reviewed by Warnecke & Heinz, 2003) . Finally, these ceramides react with UDP-glucose, catalysed by glucosylceramide synthase, resulting in GluCer (Leipelt et al., 2001) (Fig. 1) . Since it has been suggested that Sac. cerevisiae and Sch. pombe lack most of the genes that encode the enzymes for GluCer synthesis, there is currently little knowledge about the fungal genes that are involved in GluCer synthesis. It was recently reported that a Cr. neoformans strain that lacks the GluCer synthase gene and cannot synthesize GluCer was incapable of growing in neutral and alkaline solutions in vitro, which reduces its pathogenicity in its host (Rittershaus et al., 2006) . In contrast, disruption of the GluCer synthase gene (HSX11) in C. albicans does not affect the growth of its unicellular or filamentous forms (Leipelt et al., 2001 ).
Previously, we characterized the sphingolipid D 8 -desaturase gene (SLD1) from C. albicans and constructed a disruptant of this gene. Compared to wild-type, the C. albicans sld1 disruptant had a decreased hyphal growth rate and was highly sensitive to SDS and fluconazole (Oura & Kajiwara, 2008) . Therefore, it was suggested that (E,E)-sphinga-4,8-dienine and/or (E,E)-9-methylsphinga-4,8-dienine in ceramide and GluCer (Fig. 1 ) play a role in the morphogenesis of this fungus. More recently, two genes encoding a putative sphingolipid C9-methyltransferase in F. graminearum (named FgMT1 and FgMT2) were characterized (Ramamoorthy et al., 2009) . Although the DFgmt1 mutant was able to produce GluCers, including (E,E)-9-methylsphinga-4,8-dienine (C9-methylated GluCer), similarly to the wild-type, the mutant had a reduced amount of this GluCer compared to the wild-type. The DFgmt2 mutant also exhibited a severe growth defect, produced abnormal conidia, and showed reduced disease symptoms in wheat and much delayed disease symptoms in Arabidopsis thaliana. These results suggested that C9-methylated GluCers play a functional role in the growth, differentiation and virulence of this fungus. Therefore, the structure of the LCB portion of GluCer was suggested to be responsible for the determination of biological phenomena in pathogenic fungi.
In this study, we focused on two other genes involved in GluCer biosynthesis, the MTS1 and HSX11 genes in C. albicans. We constructed a null mutant of MTS1 to determine the function of this gene in C. albicans, and to investigate the effects of MTS1 disruption on the morphogenesis of this fungus. We also constructed a hsx11 null mutant of C. albicans and compared the phenotype of this mutant with that of the mts1 null mutant. Both the mts1 and hsx11 mutants had an obvious delay in filamentous growth compared to the isogenic wild-type strains. The mutants were also found to differ in their susceptibility to some antifungal drugs and environmental stressors.
METHODS
Media, growth conditions, and basic techniques. The C. albicans strains used and constructed in this study are summarized in Table 1 . Strains were typically grown at 30 uC in YPD medium [1 % Bacto yeast extract, 2 % Bacto peptone, 2 % dextrose (glucose) (pH 5.6)] or complete minimal (CM) medium (Ausubel et al., 1992) without uracil and/or arginine. The rate of growth was measured as OD 600 using an Ultrospec 3000 spectrophotometer (Pharmacia Biotech). The yeast-tohypha transition was induced at 37 uC in both solid and liquid media. For the solid transition medium, we used 10 % fetal bovine serum medium . For the liquid transition medium, we used 10 % fetal bovine serum in YPD at pH 7.2. Filamentation in the liquid medium was induced by inoculating 2610 6 -5610 6 cells ml 21 and incubating at 37 uC. For spot tests, cells were grown overnight at 30 uC in YPD medium and then tenfold serial dilutions were spotted onto YPD agar plates and grown for 1-2 days at 30 uC. The antifungals used in this study were amphotericin B (Wako Pure Chemical Industries), fluconazole (LKT Laboratories), micafungin (Astellas Pharma) and terbinafine (LKT Laboratories).
Escherichia coli DH5a and the cloning vector pBluescript II SK+ (Stratagene) were used to manipulate the DNA. General recombinant DNA procedures were performed as described by Sambrook et al. (1989) . C. albicans was transformed following the method described by Umeyama et al. (2005) .
Plasmid construction. The primers used in this study are listed in Table 2 . The MTS1 DNA fragment was PCR amplified using primers mts1-clo5 and mts1-clo3, with TUA4 chromosomal DNA as a template. The PCR products were cloned into the EcoRV site of pBluescript II SK+ to generate pBS-MTS1. The nucleotide sequence of the MTS1 DNA was confirmed by DNA sequencing. The 1.5 kb BamHI-XhoI DNA fragment from pBS-MTS1 was inserted into the BamHI-XhoI sites of pFLAG-Act1 to generate pFLAG-Act1-MTS1. The HSX11 DNA fragment was PCR amplified using primers hsx11-clo5 and hsx11-clo3, with TUA4 chromosomal DNA as a template. These products were cloned into the EcoRV site of pBluescript II SK+ to generate pBS-HSX11. The nucleotide sequence of this fragment was confirmed. The 1.6 kb BamHI-XhoI DNA fragment from pBS-HSX11 was inserted into the BamHI-XhoI sites of pFLAG-Act1 (Umeyama et al., 2002) to generate pFLAG-Act1-HSX11.
Disruption of MTS1 in C. albicans and construction of a mts1 mutant expressing MTS1. To disrupt MTS1 in a diploid C. albicans strain, two markers were used. The 0.5 kb DNA fragment corresponding to the 39 end of MTS1 was PCR amplified using primers mts1-mutNot5 and mts1-mut-Sac3, digested with NotI and SacI, and then cloned into the NotI-SacI sites of pBS-hph200-URA3 and pUC19-ARG4 to generate pBS-hph200-URA3-NS and pUC-ARG4-NS, respectively. The 0.5 kb DNA fragment corresponding to the 59 end of MTS1 was PCR amplified using primers mts1-mut-Kpn5 and mts1-mut-Xho3, digested with KpnI and XhoI, and then cloned into the KpnI-XhoI sites of pBS-hph200-URA3-NS to generate pBS-hph200-URA3-disMTS1. The 0.5 kb DNA fragment corresponding to the 59 end of MTS1 was PCR amplified using primers mts1-mut-Sph5 and mts1-mut-Kpn3, digested with SphI and KpnI, and then cloned into the SphI-KpnI sites of pUC-ARG4-NS to generate pUC-ARG4-disMTS1.
The 3.1 kb KpnI-SacI fragment of pBS-hph200-URA3-disMTS1 was used to transform the C. albicans Arg -Ura -strain TUA4 to generate a Ura + transformant (MTS101). Then the 3.1 kb SphI-SacI fragment of pUC-ARG4-disMTS1 was used to transform the MTS101 strain (Arg -) to generate MTS102. The resulting Ura
+

Arg
+ transformant MTS102 was plated on medium containing 5-fluoroorotic acid to isolate the Ura -segregant (MTS103). To confirm gene disruption, genomic DNA was isolated from each strain, digested with EcoRV, run on a 1 % agarose gel, and then transferred onto a Hybond-N+ nylon membrane (Amersham Biosciences). Southern hybridization was performed using a 32 Plabelled probe in a solution containing 56 SSC, 66 Denhart's solution and 0.1 mg herring sperm DNA ml 21 at 65 uC according to the methods of Sambrook et al. (1989) . The MTS1 gene was reintroduced into the Ca-RP10 locus of the null mutant by using AatI-digested pFLAG-Act1-MTS1 to transform strain MTS103, Table 1 . Yeast strains generated and tested in this study
Strain
Genotype Reference TUA4 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 NIID* TUA6 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 RP10 : : p3HA-ACT1 NIID* MTS101 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 mts1D : : hph200-URA3-hph200/MTS1 This work MTS102 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 mts1D : : hph200-URA3-hph200/ mts1D : : ARG4
This work MTS103 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 mts1D : : hph200/mts1D : : ARG4 This work MTS104 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 mts1D : : hph200/mts1D : : ARG4 RP10 : : pFLAG-ACT1
This work MTS105 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 mts1D : : hph200/mts1D : : ARG4 RP10 : : pFLAG-ACT1-MTS1
This work HSX101 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 hsx11D : : hph200-URA3-hph200/HSX11 This work HSX102 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 hsx11D : : hph200-URA3-hph200/ hsx11D : : ARG4
This work HSX103 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 hsx11D : : hph200/hsx11D : : ARG4 This work HSX104 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 hsx11D : : hph200/hsx11D : : ARG4 RP10 : : pFLAG-ACT1
This work HSX105 ura3D : : imm434/ura3D : : imm434 arg4D : : hisG200/arg4D : : hisG200 hsx11D : : hph200/hsx11D : : ARG4 RP10 : : pFLAG-ACT1-HSX11
This work *NIID, National Institute of Infectious Diseases, Japan.
T. Oura and S. Kajiwara generating MTS105. The AatI-digested empty vector pFLAG-Act1 was integrated into strain MTS103 to generate MTS104 as a control.
Disruption of HSX11 in C. albicans and construction of a hsx11 strain expressing HSX11. To disrupt HSX11 in C. albicans, the ARG4 and URA3 genes were used as markers. The 0.6 kb DNA fragment corresponding to the 39 end of HSX11 was PCR amplified using primers hsx11-mut-Not5 and hsx11-mut-Sac3, digested with NotI and SacI, and then cloned into the NotI-SacI sites of pBShph200-URA3 (Oura & Kajiwara, 2008 ) and pUC19-ARG4 to generate pBS-hph200-URA3-NS and pUC-ARG4-NS, respectively. The 0.6 kb DNA fragment corresponding to the 59 end of HSX11 was PCR amplified using primers hsx11-mut-Kpn5 and hsx11-mut-Xho3, digested with KpnI and XhoI, and then cloned into the KpnI-XhoI sites of pBS-hph200-URA3-NS to generate pBShph200-URA3-disHSX11. The 0.6 kb DNA fragment corresponding to the 59 end of HSX11 was PCR amplified using primers hsx11-mutBam5 and hsx11-mut-Kpn3, digested with BamHI and KpnI, and then cloned into the BamHI-KpnI sites of pUC-ARG4-NS to generate pUC-ARG4-disHSX11.
The 3.2 kb KpnI-SacI fragment of pBS-hph200-URA3-disHSX11 was used to transform the C. albicans Arg -Ura -strain TUA4 to generate the Ura + transformant HSX101. Then the 3.2 kb BamHI-SacI fragment of pUC-ARG4-disHSX11 was used to transform HSX101 (Arg -) to generate HSX102. The resulting Ura + Arg + transformant, HSX102, was plated on a medium containing 5-fluoroorotic acid to isolate the Ura -segregant (HSX103). To confirm gene disruption, genomic DNA was isolated from each strain, digested with SpeI, run on a 1 % agarose gel, and then transferred onto a Hybond-N+ nylon membrane (Amersham Biosciences). Southern hybridization was performed using a 32 P-labelled probe in a solution containing 56 SSC, 66 Denhart's solution, and 0.1 mg herring sperm DNA ml 21 at 65 uC according to the methods of Sambrook et al. (1989) . The HSX11 gene was reintroduced into the RP10 locus of the null mutant by using AatI-digested pFLAG-Act1-HSX11 to transform strain HSX103, generating HSX105. The AatI-digested empty pFLAG-Act1 vector was integrated into strain HSX103 to generate HSX104.
Determination of glucosylceramides. GluCers were extracted essentially as described by Saito et al. (2005) with the following modifications. The lyophilized cells (50 mg) were treated with chloroform/methanol (1 : 1, v/v) and 2.0 ml 0.8 M KOH/methanol for 5 min with a subsonic homogenizer (HOM-100, Asahi Grass) and then incubated at 42 uC for 30 min. Organic salt was collected from the homogenate after mixing with 5.0 ml chloroform and 2.25 ml water, dried using a rotary evaporator, and dissolved in 100 ml chloroform/methanol (1 : 1, v/v). Ten microlitres of the extract was spotted onto a TLC plate (silica gel 60, Merck) and the chromatogram was developed using chloroform/methanol/water (65 : 16 : 2, by vol.) as mobile phase. After development, the plates were sprayed with orcinol/sulfuric acid reagent [0.1 g orcinol in 45 ml of a sulfuric acid/ water/ethanol solution (5 : 13 : 27, by vol.)] and heated on a hotplate to detect the GluCers. GluCers prepared from the mushroom Grifola frondosa were used as standards.
Sphingoid base analysis. Analysis of the sphingoid base composition was performed essentially as described by Tanji et al. (2004) with the following modifications. The lyophilized cells were treated in chloroform/methanol (2 : 1, v/v) for 10 min with a subsonic homogenizer (HOM-100, Asahi Grass). Then the total lipids were extracted with 4 vols each of chloroform/methanol (2 : 1, v/v) and chloroform/ methanol (1 : 2, v/v) and hydrolysed in 0.4 M KOH/methanol at 37 uC for 2 h. After washing, the organic phase was dried on a rotary evaporator to yield the alkali-stable lipids. GluCers were isolated on preparative TLC plates that were developed in chloroform/methanol (95 : 12, v/v) to separate the GluCers from other lipids. The GluCers obtained were degraded with 10 % Ba(OH) 2 /dioxane (1 : 1, v/v) and the released sphingoid bases were extracted with diethyl ether and reacted with 0.2 M sodium periodate for 2 h to obtain the fatty aldehydes. The fatty aldehydes were extracted in dichloromethane and analysed by GLC (GC-18A, Shimadzu) on a 0.25 mm650 m CP-Sil 88 capillary column (Varian). The initial column temperature of 150 uC was maintained for 2 min, increased by 2 uC min 21 to 190 uC, and then maintained for 6 min.
RESULTS
Construction of mts1 and hsx11 mutants
The C. albicans ORF (orf19.4831) encoding a homologue of the sphingolipid C9-methyltransferase of Pichia pastoris was 
previously identified in the C. albicans genome (Ternes et al., 2006) . However, this ORF has not been further characterized. To determine whether this ORF (named MTS1) encodes the C. albicans C9-methyltransferase, we constructed mts1 mutants as described in Methods. For the first allele, MTS1 was replaced with an hph200-URA3-hph200 cassette (MTS101) and the remaining allele was replaced with ARG4. The resulting strain was called MTS102. The URA3 gene was excised from MTS102 to generate the Ura-auxotrophic derivative MTS103. Southern blot analysis was performed to confirm that the mutant obtained had a disrupted MTS1 locus (data not shown). Next, to construct the MTS1-recovered strain, an MTS expression plasmid (pFLAG-Act1-MTS1) and its vector (pFLAG-ACT1), which contain the URA3 gene as a selectable marker, were introduced into the RP10 locus (Murad et al., 2000) in the genome of the mts1 mutant strain MTS103, yielding strains MTS105 and MTS104, respectively.
It was reported that disrupting the HSX11 gene in C. albicans does not affect the growth of either the yeast or filamentous forms (Leipelt et al., 2001) . However, some researchers have suggested that GluCers play important roles in the growth, differentiation and pathogenicity of other fungi. Therefore, to investigate the function of HSX11 in detail, we constructed hsx11 mutants as described in Methods. For the first allele, HSX11 was replaced with an hph200-URA3-hph200 cassette (HSX101) and the remaining allele was replaced with ARG4. The resulting strain was termed HSX102. The URA3 gene was excised from HSX102, generating the Ura-auxotrophic derivative HSX103. Southern blot analysis was performed to confirm that the mutant obtained had a disrupted HSX11 locus (data not shown). Next, to construct the HSX11-recovered strain, a HSX11 expression plasmid (pFLAG-Act1-HSX11) and the vector (pFLAG-ACT1), which contain the URA3 gene as a selectable marker, were introduced into the RP10 locus (Murad et al., 2000) on the chromosome of the hsx11 mutant strain HSX103, yielding strains HSX105 and HSX104, respectively.
Sphingoid base analysis of the mts1 mutants
To investigate the profile of sphingoid base residues in GluCers of the C. albicans transformants, GluCers were isolated from MTS104 (mts1 mutant), MTS105 (MTS1-restored strain) and their corresponding wild-type strain, TUA6. The amounts of GluCers were highly similar among these strains (data not shown). Their sphingoid base compositions were also compared (Fig. 2) . The GluCers in the TUA6 strain contained three sphingoid bases: (E)-sphing-4-enine, (E,E)-sphinga-4,8-dienine and (E,E)-9-methylsphinga-4,8-dienine. In contrast, the GluCers in the MTS104 strain lacked (E,E)-9-methylsphinga-4,8-dienine and contained (E)-sphing-4-enine and (E,E)-sphinga-4,8-dienine. The MTS105 strain recovered the ability to produce (E,E)-9-methylsphinga-4,8-dienine, although the proportion of this sphingoid base in the GluCers was lower than that of TUA6 (wild-type), making (E,E)-sphinga-4,8-dienine the most abundant molecule in the GluCers of MTS105. These results indicate that the MTS1 protein (MTS1p) is the only enzyme that introduces a methyl group at the C9 position of the LCB of ceramides in C. albicans.
GluCer analysis of hsx11 mutants
To confirm the absence of GluCers in the hsx11 disruptant, alkali-stable lipids were isolated from HSX104 (hsx11 mutant), HSX105 (HSX11-restored strain) and the wild-type strain, TUA6. The amounts of GluCers were compared in these strains by TLC (Fig. 3) . The HSX105 and TUA6 strains produced similar amounts of GluCers. In contrast, the HSX104 strain completely lacked GluCers. These results show that the hsx11 mutants are incapable of synthesizing GluCers and that HSX11p is the Fig. 2 . GLC analysis of fatty aldehydes derived from sphingoid bases. Cells of strains TUA6 (MTS1/MTS1) (a), MTS104 (mts1/ mts1) (b) and MTS105 (mts1/mts1 MTS1) (c) were grown overnight at 30 6C. Sphingoid base fractions were subjected to periodate oxidation to obtain fatty aldehydes and then identified by comparing their retention times to known standards prepared from Grifola frondosa sphingoid bases. The abbreviations for sphingoid bases are as follows: d18 : 1 D4 , 4-trans-sphingenine; d18 : 2 only enzyme involved in synthesis of GluCers in C. albicans, findings consistent with a previous report (Leipelt et al., 2001 ).
Growth and morphogenesis of the C. albicans gene disruptants
The (E,E)-9-methylsphinga-4,8-dienine in GluCers is thought to be essential to maintain sufficient membrane fluidity in Kluyveromyces lactis in a low-temperature environment (Tanji et al., 2004) . Therefore, to investigate the roles of fungal-specific GluCers during growth at low temperatures, we examined the growth rate of the mts1 disruptant at 30 uC and 10 uC in liquid YPD medium (Fig. 4 ). There were no significant differences in growth rate between the mts1 disruptant and the wild-type strain at either temperature. This result indicates that the C9-methylation of GluCer is not necessary for the vegetative growth of C. albicans at low temperatures.
To investigate the effects of the mts1 and hsx11 disruptions on the yeast-to-hypha transition in C. albicans, the genedisrupted strains (MTS104 and HSX104) were incubated in either solid or liquid medium containing 10 % serum. On 10 % serum agar medium at 37 u C, the hyphal growth of both MTS104 and HSX104 was clearly slower than that of wild-type TUA6 (Fig. 5) . These phenotypes were restored to wild-type by introducing MTS1 and HSX11 into the mts1 and hsx11 mutants, respectively (strains MTS105 and HSX105). On the other hand, there were no significant differences among these C. albicans strains in hyphal formation in liquid YPD medium (pH 7.2) containing 10 % serum (data not shown). These results suggested that not only GluCer synthesis but also the C9-methylation of the LCB play roles in hyphal formation of C. albicans on solid medium.
Susceptibilities of the mts1 and hsx11 disruptants to stressors and antifungals
To investigate the additional effects of the absence of GluCer and C9-methylated GluCer in C. albicans, the mts1 and hsx11 disruptants were examined for their susceptibilities to a wide range of stress conditions using dilution drop assays (Fig. 6) . The stressors high temperature (42 u C), salt (1 M NaCl), 6 % ethanol and 50 mg ml
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Calcofluor white (CFW) did not affect MTS104 and HSX104 more than TUA6, MTS105 and HSX105. However, MTS104 was more susceptible than TUA6 and MTS105 to the b-1,3-glucan synthase inhibitor micafungin, while the other antifungals examined did not induce different effects on these strains. On the other hand, Fig. 3 . TLC analysis of alkali-stable lipids. The alkali-stable lipids extracted from lyophilized cells of TUA6 (HSX11/HSX11) (lane 2), HSX104 (hsx11/hsx11) (lane 3) and HSX105 (hsx11/ hsx11+HSX11) (lane 4) were dissolved in chloroform/methanol (1 : 1, v/v), spotted on a silica gel 60 TLC plate, and the chromatogram was developed using chloroform/methanol/water (65 : 16 : 2, by vol.) as mobile phase. After development, the plates were sprayed with orcinol/sulfuric acid reagent and heated on a hotplate to detect the GluCers. GluCers prepared from Grifola frondosa were used as standards (lane 1). Fig. 4 . Growth of C. albicans strains in liquid YPD medium. Cells of strains TUA6 (wild-type, $), MTS104 (mts1/mts1, m) and MTS105 (mts1/mts1+MTS1, &) were pre-cultured overnight at 30 6C and then inoculated into 50 ml medium and grown to OD 600 0.2 on a reciprocal shaker (130 r.p.m.) at 30 6C (a) and 10 6C (b). Vertical bars represent the standard errors of three independent experiments. HSX104 was more sensitive than TUA6 to 0.05 % SDS, while MTS104 showed no sensitivity to 0.05 % SDS. Moreover, HSX104 was more susceptible than TUA6 and HSX105 to the lanosterol 14a-demethylase inhibitor fluconazole, while the other tested antifungals did not induce different effects among these three strains. Thus MTS104 had a different phenotype from HSX104 when treated with SDS and certain antifungals. (mts1/mts1), MTS105 (mts1/mts1+MTS1), HSX104 (hsx11/hsx11) and HSX105 (hsx11/hsx11+HSX11) were grown overnight at 30 6C. Then 10 5 cells were spotted onto agar medium containing 10 % serum and grown for 7 days at 37 6C. The results of a representative experiment are shown; four additional independent experiments showed the same results. Fig. 6 . Susceptibility of C. albicans strains to stressors and antifungals. Cells of strains TUA6 (wild-type), MTS104 (mts1/ mts1), MTS105 (mts1/mts1+MTS1), HSX104 (hsx11/hsx11) and HSX105 (hsx11/hsx11+HSX11) were grown overnight at 30 6C; then tenfold serial dilutions of the cultures were spotted onto the indicated YPD agar plates and grown for 1 to 2 days at 30 6C. AMB, amphotericin B; CFW, Calcofluor white; FCZ, fluconazole; MFG, micafungin; TB, terbinafine.
DISCUSSION
In this study, we characterized the sphingolipid C9-methyltransferase gene (MTS1) from C. albicans and constructed a disruptant of this gene by replacing the two MTS1 alleles with two different marker genes. To our knowledge this is the first report of the physiological characterization of a C. albicans mutant with a disrupted sphingolipid C9-methyltransferase gene. We also constructed a disruptant of the HSX11 gene, encoding GluCer synthase, and compared its phenotype to that of the wild-type strain.
Based on the results of the LCB analysis of its GluCers, the mts1 mutant contained only the sphingoid bases (E)-sphing-4-enine and (E,E)-sphinga-4,8-dienine, but not (E,E)-9-methylsphinga-4,8-dienine. The MTS1-restored strain contained all three sphingoid bases (E)-sphing-4-enine, (E,E)-sphinga-4,8-dienine and (E,E)-9-methylsphinga-4,8-dienine in its GluCers. These results showed that MTS1p is a unique enzyme that introduces a methyl group at the C9 position of the LCB in ceramides. It was previously shown that a P. pastoris strain lacking the sphingolipid C9-methyltransferase gene produced no (E,E)-9-methylsphinga-4,8-dienine (Ternes et al., 2006) , similar to the mts1 mutant of C. albicans. Moreover the databases for Cr. neoformans, Debaryomyces hansenii, Kluyveromyces lactis, Saccharomyces kluyveri and Yarrowia lipolytica indicate that these yeast species have only one sphingolipid C9-methyltransferase gene homologue in their genomes. Therefore, most other yeast species producing GluCers may have only one sphingolipid C9-methyltransferase gene. On the other hand, the genomes of both the filamentous ascomycetes A. nidulans and F. graminearum contain two sequences that are homologous to the sphingolipid C9-methyltransferase gene (Ternes et al., 2006) . Moreover, it was shown that F. graminearum has two genes with sphingolipid C9-methyltransferase activity (Ramamoorthy et al., 2009) .
The amounts of GluCer in the mts1 mutant and wild-type C. albicans strains are highly similar. This indicates that C9-methylation by MTS1p has little influence on subsequent GluCer synthesis. In contrast, disrupting the HSX11 gene in C. albicans leads to the loss of GluCers, indicating that HSX11p is the only enzyme that combines glucose with ceramide for GluCer synthesis. This result is consistent with the first report on hsx11 mutants of C. albicans (Leipelt et al., 2001 ).
The wild-type and mts1 disruptant strains of C. albicans had the same growth rate at 30 u C in liquid YPD medium. A P. pastoris strain lacking the sphingolipid C9-methyltransferase gene did not have impaired growth compared to the wild-type strain, whereas the F. graminearum DFgmt2 mutant exhibited severe growth defects (Ternes et al., 2006; Ramamoorthy et al., 2009) . It therefore appears that sphingolipid C9-methyltransferase is not necessary for the vegetative growth of yeast but is necessary for the growth of filamentous fungi. Previously, (E,E)-9-methylsphinga-4,8-dienine in the GluCers of K. lactis was assumed to be essential to maintain sufficient membrane fluidity in a low-temperature environment (Tanji et al., 2004) . However, the authors neither constructed any sphingolipid C9-methyltransferase gene mutant of K. lactis nor investigated the growth of any gene mutants of the yeast under low-temperature conditions. In our work, the mts1 mutant of C. albicans had the same growth rate as the wild-type strain, indicating that C9-methylated GluCer is not necessary for the yeast growth of this fungus at 10 u C or 30 u C. Although the mechanisms that fungi use to adapt to low-temperature stress are complex and many factors are thought to affect the stress response, the loss of C9-methylated GluCers is suggested to not influence the yeastlike growth of fungi at low temperature.
When the mts1 and hsx11 disruptants were grown in liquid medium to induce the hyphal form, they were able to elongate and produce their germ tubes normally. However, when grown on hyphal-inducing solid media, both the mts1 and hsx11 disruptants showed slower elongation than the wild-type. In addition, in our previous report, a sld1 mutant of C. albicans, which is unable to produce not only GluCers including (E,E)-sphinga-4,8-dienine as a sphingoid base residue (D 8 -desaturated GluCer) but also C9-methylated GluCers, showed slower elongation than the wild-type, similar to our mts1 and hsx11 disruptants. These results suggest that GluCers, including C9-methylated LCB, are at least necessary for normal hyphal elongation of C. albicans on solid media. Filamentous growth of C. albicans is influenced by the physical environment. Several other C. albicans genes needed for filamentous growth on solid medium have been reported (reviewed by Kumamoto & Vinces, 2005) . Thus, several other C9-methylated GluCers also may be involved in the induction of the filamentous form of this fungus on solid media. Some GlyCers in fungi and plants are thought to be highly active in inducing fruiting body formation in Schizophyllum commune (Kawai & Ikeda, 1985; Kawai et al., 1986) . A structural analysis of these GlyCers revealed that C9-methylation in the sphingoid base moiety of fungal GlyCer is essential, while the sugar moiety has no effect. Moreover, the DFgmt2 mutant of F. graminearum, which has been shown to have reduced amounts of C9-methylated GluCers compared to the wild-type, was defective in mycelial growth (Ramamoorthy et al., 2009) . These results and our findings suggest that C9-methylated GluCers may be active in inducing hyphal morphogenesis of C. albicans.
The C. albicans hsx11 disruptant was more sensitive to SDS than the wild-type, but the cell wall stress inducer CFW did not induce different growth effects on the hsx11 disruptant or wild-type. In addition, the C. albicans hsx11 disruptant was more susceptible than the wild-type to the lanosterol 14a-demethylase inhibitor fluconazole. Fluconazole disrupts cell membrane structures by inhibiting the synthesis of ergosterol, which is a major membrane component. Our data suggest that the loss of GluCer leads to the disruption of cell membrane integrity in C. albicans. Moreover, the sphingolipids that are enriched in detergent-resistant membrane microdomains, also known as lipid rafts, are known to be important for normal hyphal growth in C. albicans (Martin & Konopka, 2004) . Martin & Konopka (2004) showed that myriocin, a specific inhibitor of serine palmitoyltransferase, which catalyses the first step of sphingolipid biosynthesis, affects hyphal elongation in C. albicans. Lipid rafts have been implicated in numerous cellular processes, including signal transduction, protein and lipid sorting, cellular entry of toxins and viruses, and viral budding (reviewed by Chazal & Gerlier, 2003; Bollinger et al., 2005) . Moreover, an antimicrobial peptide inhibitor of the fungal plasma membrane ATPase (Pma1p), which is known to be associated with lipid rafts, blocks the azole resistance of C. albicans (Monk et al., 2005) . GluCer is a major component of lipid rafts in most fungi. Therefore, the C. albicans hsx11 disruptant may be sensitive to SDS and fluconazole due to defects in lipid rafts and thereby show abnormal hyphal growth in response to these agents. Future experiments should examine the lipid composition of membrane detergent-resistant microdomains and the membrane fluidity of the C. albicans hsx11 mutant in detail.
On the other hand, the C. albicans mts1 disruptant had susceptibility to SDS and fluconazole similar to the wildtype strain, although unlike the hsx11 mutant it was more susceptible than the wild-type to the b-1,3-glucan synthase inhibitor micafungin. These results indicate that the membrane structure of the C. albicans mts1 disruptant is not disturbed, suggesting that the abnormal hyphal growth of this disruptant is different from those of other GluCer synthesis gene disruptants. Micafungin disrupts the fungal cell wall structure by inhibiting cell wall synthesis. Although the detailed mechanisms of this process are still unclear, deleting the MTS1 gene may affect fungal cell wall synthesis during hyphal growth.
The micafungin susceptibility of the single mts1 mutant and the MTS1-restored strain was similar to that of the mts1 knockout mutant. This result indicates that both alleles of MTS1 are necessary for resistance to micafungin. On the other hand, the single disruptant of the HSX11 gene showed SDS and fluconazole resistance similar to the wildtype while the HSX11-restored strain had high susceptibility to SDS and fluconazole, like the hsx11 knockout strain. In this study, we used the constitutive ACT1 promoter instead of the native HSX11 promoter to restore the expression of the HSX1 gene in the knockout strain. The difference in susceptibility to SDS and fluconazole between the single hsx11 disruptant and the HSX11-restored strain may be due to the difference in the promoters used for the expression of the HSX11 gene.
The findings of this study suggest that C9-methylated GluCer not only plays functional roles in hyphal morphogenesis but also contributes to cell wall synthesis in C. albicans. We have clarified the genes related to the biosynthetic pathway of GluCer in C. albicans. In contrast, the entire metabolic pathway of GluCer, especially its degradation, remains unclear because no fungal genes for GluCer degradation, such as a glucosylceramidase gene, have been identified. To further understand the physiological function of GluCer, it will be necessary to analyse the degradation pathway of GluCer.
